Recover Investment Losses: Class Action Initiated Against aTyr Pharma, Inc. (ATYR)

NEW YORK, NY / ACCESS Newswire / November 24, 2025 / If you suffered a loss on your aTyr Pharma, Inc. (NASDAQ:ATYR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/atyr-pharma-inc-lawsuit-submission-form?prid=179045&wire=1&utm_campaign=24 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or […]

Securities Class Action Lawsuit Filed Against Inspire Medical Systems, Inc. (INSP) – Levi & Korsinsky Represents Shareholders

NEW YORK, NY / ACCESS Newswire / November 24, 2025 / If you suffered a loss on your Inspire Medical Systems, Inc. (NYSE:INSP) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/inspire-medical-systems-inc-lawsuit-submission-form?prid=179044&wire=1&utm_campaign=13 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com

ARTE Generali Partners with Verified Market Research for Global Fine Art Insurance Market Study

ARTE Generali Partners with Verified Market Research for Global Fine Art Insurance Market Study ARTE Generali, a specialised division of the global insurance group dedicated to art collections, cultural institutions and high-value assets, collaborated with Verified Market Research(R) (VMR) to strengthen its strategic understanding of the global fine art insurance market. Through the customised Global

Planet Based Foods Global Inc. Announces Results of Annual General Meeting of Shareholders

Vancouver, British Columbia–(Newsfile Corp. – November 24, 2025) – Planet Based Foods Global Inc. (CSE: PBF) (OTC Pink: PBFFF) (FSE: AZ00) (the “Company” or “PBFG“) is pleased to announce the voting results from its annual general meeting of shareholders (the “AGM“) held today in Vancouver, British Columbia, for the financial years ended December 31, 2023

Securities Class Action Lawsuit Filed Against Baxter International, Inc. (BAX) – Levi & Korsinsky Represents Shareholders

NEW YORK, NY / ACCESS Newswire / November 24, 2025 / If you suffered a loss on your Baxter International, Inc. (NYSE:BAX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/baxter-international-inc-lawsuit-submission-form?prid=179069&wire=1&utm_campaign=13 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Levi & Korsinsky Urges Firefly Aerospace Inc. (FLY) Shareholders to Act Before Lead Plaintiff Deadline January 12, 2026

NEW YORK, NY / ACCESS Newswire / November 24, 2025 / If you suffered a loss on your Firefly Aerospace Inc. (NASDAQ:FLY) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/firefly-aerospace-inc-lawsuit-submission-form?prid=179041&wire=1&utm_campaign=19 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

MRX DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Marex Group plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRX

New York, New York–(Newsfile Corp. – November 24, 2025) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Marex Group plc (NASDAQ: MRX) between May 16, 2024 and August 5, 2025, both dates inclusive (the “Class Period”), of the important December 8, 2025 lead plaintiff deadline. SO WHAT: If

Frost & Sullivan Published the 2025 Blue Book on the Current Status and Trends of Global Expansion of Chinese Medical Devices

Shanghai, China–(Newsfile Corp. – November 24, 2025) – Frost & Sullivan has conducted comprehensive research on the global medical device industry and published the “2025 Blue Book on the Current Status and Trends of Global Expansion of Chinese Medical Devices” on May 30, 2025. The blue book aims to provide a comprehensive analysis of the

Frost & Sullivan Presents Haohai Biological Technology with the “2025 Global Premium Hyaluronic Acid Technology Leadership Award”

Shanghai, China–(Newsfile Corp. – November 24, 2025) – On the evening of August 27, the 2025 Frost & Sullivan Global Growth, Innovation & Leadership Awards, China Awards, and Best Practice Awards were grandly unveiled at the Frost & Sullivan Global Growth, Innovation and Leadership Award Ceremony 2025 and VIP Client Appreciation Gala Banquet. Based on

Muscular Dystrophy Association Calls FDA Approval of Novartis’ Itvisma (onasemnogene abeparvovec-brve) a Major Step Forward for the Spinal Muscular Atrophy Community

New York, Nov. 24, 2025 (GLOBE NEWSWIRE) — The Muscular Dystrophy Association (MDA) today called the U.S. Food and Drug Administration's approval of Itvisma (onasemnogene abeparvovec-brve), developed by Novartis, a major step forward for families living with spinal muscular atrophy (SMA). The newly approved therapy is indicated for children two years and older, teens, and

Scroll to Top